annual D&A:
$35.24M-$1.28M(-3.51%)Summary
- As of today (June 30, 2025), LGND annual depreciation & amortization is $35.24 million, with the most recent change of -$1.28 million (-3.51%) on December 31, 2024.
- During the last 3 years, LGND annual D&A has fallen by -$15.71 million (-30.83%).
- LGND annual D&A is now -31.62% below its all-time high of $51.53 million, reached on December 31, 2022.
Performance
LGND Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$8.77M+$143.00K(+1.66%)Summary
- As of today (June 30, 2025), LGND quarterly depreciation & amortization is $8.77 million, with the most recent change of +$143.00 thousand (+1.66%) on March 31, 2025.
- Over the past year, LGND quarterly D&A has increased by +$5000.00 (+0.06%).
- LGND quarterly D&A is now -60.20% below its all-time high of $22.04 million, reached on December 31, 2019.
Performance
LGND quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$35.24M+$5000.00(+0.01%)Summary
- As of today (June 30, 2025), LGND TTM depreciation & amortization is $35.24 million, with the most recent change of +$5000.00 (+0.01%) on March 31, 2025.
- Over the past year, LGND TTM D&A has dropped by -$543.00 thousand (-1.52%).
- LGND TTM D&A is now -33.73% below its all-time high of $53.18 million, reached on September 30, 2022.
Performance
LGND TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
LGND Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.5% | +0.1% | -1.5% |
| 3 y3 years | -30.8% | -35.7% | -31.6% |
| 5 y5 years | -19.4% | +37.5% | -19.6% |
LGND Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.6% | at low | -35.7% | +1.9% | -33.7% | +0.3% |
| 5 y | 5-year | -31.6% | +26.0% | -35.7% | +107.7% | -33.7% | +26.0% |
| alltime | all time | -31.6% | +3249.7% | -60.2% | +350.6% | -33.7% | +6176.6% |
LGND Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $8.77M(+1.7%) | $35.24M(+0.0%) |
| Dec 2024 | $35.24M(-3.5%) | $8.63M(-4.1%) | $35.24M(-0.8%) |
| Sep 2024 | - | $8.99M(+1.6%) | $35.53M(+1.1%) |
| Jun 2024 | - | $8.85M(+1.0%) | $35.15M(-1.8%) |
| Mar 2024 | - | $8.77M(-1.7%) | $35.79M(-2.0%) |
| Dec 2023 | $36.52M(-29.1%) | $8.92M(+3.5%) | $36.52M(-6.1%) |
| Sep 2023 | - | $8.61M(-9.3%) | $38.90M(-11.2%) |
| Jun 2023 | - | $9.49M(-0.0%) | $43.80M(-7.6%) |
| Mar 2023 | - | $9.50M(-15.9%) | $47.39M(-8.0%) |
| Dec 2022 | $51.53M(+1.2%) | $11.30M(-16.3%) | $51.53M(-3.1%) |
| Sep 2022 | - | $13.51M(+3.2%) | $53.18M(+1.7%) |
| Jun 2022 | - | $13.09M(-4.1%) | $52.29M(+1.5%) |
| Mar 2022 | - | $13.64M(+5.4%) | $51.50M(+1.1%) |
| Dec 2021 | $50.95M(+82.2%) | $12.95M(+2.7%) | $50.95M(+0.3%) |
| Sep 2021 | - | $12.61M(+2.6%) | $50.81M(+18.9%) |
| Jun 2021 | - | $12.29M(-6.1%) | $42.75M(+23.3%) |
| Mar 2021 | - | $13.09M(+2.2%) | $34.68M(+24.0%) |
| Dec 2020 | $27.97M(-36.0%) | $12.82M(+181.8%) | $27.97M(-24.8%) |
| Sep 2020 | - | $4.55M(+7.7%) | $37.19M(-9.7%) |
| Jun 2020 | - | $4.22M(-33.8%) | $41.18M(-6.0%) |
| Mar 2020 | - | $6.38M(-71.0%) | $43.83M(+0.2%) |
| Dec 2019 | $43.73M(+197.1%) | $22.04M(+157.9%) | $43.73M(+75.0%) |
| Sep 2019 | - | $8.54M(+24.3%) | $24.99M(+14.3%) |
| Jun 2019 | - | $6.87M(+9.5%) | $21.86M(+21.5%) |
| Mar 2019 | - | $6.28M(+90.4%) | $17.99M(+22.3%) |
| Dec 2018 | $14.72M(+25.6%) | $3.30M(-39.0%) | $14.72M(-5.4%) |
| Sep 2018 | - | $5.41M(+79.6%) | $15.55M(+27.9%) |
| Jun 2018 | - | $3.01M(+0.3%) | $12.16M(+3.6%) |
| Mar 2018 | - | $3.00M(-27.4%) | $11.74M(+0.2%) |
| Dec 2017 | $11.71M(+3.8%) | $4.13M(+104.9%) | $11.71M(+11.0%) |
| Sep 2017 | - | $2.02M(-22.0%) | $10.55M(-8.0%) |
| Jun 2017 | - | $2.58M(-13.2%) | $11.47M(-1.9%) |
| Mar 2017 | - | $2.98M(+0.4%) | $11.69M(+3.6%) |
| Dec 2016 | $11.29M(+329.8%) | $2.97M(+1.2%) | $11.29M(+25.3%) |
| Sep 2016 | - | $2.93M(+4.3%) | $9.01M(+34.1%) |
| Jun 2016 | - | $2.81M(+9.2%) | $6.72M(+47.6%) |
| Mar 2016 | - | $2.58M(+274.8%) | $4.55M(+73.3%) |
| Dec 2015 | $2.63M(-1.1%) | $687.00K(+6.7%) | $2.63M(+1.1%) |
| Sep 2015 | - | $644.00K(-0.3%) | $2.60M(-0.6%) |
| Jun 2015 | - | $646.00K(-0.6%) | $2.62M(-0.9%) |
| Mar 2015 | - | $650.00K(-1.4%) | $2.64M(-0.7%) |
| Dec 2014 | $2.66M(-0.2%) | $659.00K(-0.3%) | $2.66M(+0.1%) |
| Sep 2014 | - | $661.00K(-1.2%) | $2.65M(-0.3%) |
| Jun 2014 | - | $669.00K(+0.1%) | $2.66M(0.0%) |
| Mar 2014 | - | $668.00K(+1.8%) | $2.66M(-0.1%) |
| Dec 2013 | $2.66M(-2.3%) | $656.00K(-1.8%) | $2.66M(-3.4%) |
| Sep 2013 | - | $668.00K(-0.1%) | $2.76M(+1.1%) |
| Jun 2013 | - | $669.00K(-0.1%) | $2.73M(+0.3%) |
| Mar 2013 | - | $670.00K(-10.5%) | $2.72M(-0.3%) |
| Dec 2012 | $2.73M(-2.3%) | $749.00K(+17.4%) | $2.73M(+2.2%) |
| Sep 2012 | - | $638.00K(-3.6%) | $2.67M(-4.0%) |
| Jun 2012 | - | $662.00K(-2.4%) | $2.78M(-4.2%) |
| Mar 2012 | - | $678.00K(-1.9%) | $2.90M(+4.1%) |
| Dec 2011 | $2.79M(+26.1%) | $691.00K(-7.9%) | $2.79M(+27.2%) |
| Sep 2011 | - | $750.00K(-4.5%) | $2.19M(+3.8%) |
| Jun 2011 | - | $785.00K(+39.2%) | $2.11M(+4.0%) |
| Mar 2011 | - | $564.00K(+493.7%) | $2.03M(-8.2%) |
| Dec 2010 | $2.21M(-29.4%) | $95.00K(-85.8%) | $2.21M(-23.2%) |
| Sep 2010 | - | $669.00K(-4.8%) | $2.88M(-3.7%) |
| Jun 2010 | - | $703.00K(-5.6%) | $2.99M(-2.2%) |
| Mar 2010 | - | $745.00K(-2.5%) | $3.06M(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $3.13M(+197.9%) | $764.00K(-2.2%) | $3.13M(+20.2%) |
| Sep 2009 | - | $781.00K(+1.4%) | $2.61M(-15.2%) |
| Jun 2009 | - | $770.00K(-6.0%) | $3.08M(+95.5%) |
| Mar 2009 | - | $819.00K(+244.1%) | $1.57M(+49.5%) |
| Dec 2008 | $1.05M(-38.3%) | $238.00K(-80.9%) | $1.05M(+291.1%) |
| Sep 2008 | - | $1.25M(-270.5%) | $269.00K(-146.4%) |
| Jun 2008 | - | -$732.00K(-345.6%) | -$580.00K(-153.2%) |
| Mar 2008 | - | $298.00K(-154.7%) | $1.09M(-36.1%) |
| Dec 2007 | $1.71M(-89.5%) | -$545.00K(-236.6%) | $1.71M(-65.5%) |
| Sep 2007 | - | $399.00K(-57.5%) | $4.94M(-43.3%) |
| Jun 2007 | - | $938.00K(+2.6%) | $8.71M(-29.8%) |
| Mar 2007 | - | $914.00K(-66.0%) | $12.40M(-23.5%) |
| Dec 2006 | $16.22M(-13.3%) | $2.69M(-35.5%) | $16.22M(-11.4%) |
| Sep 2006 | - | $4.17M(-10.0%) | $18.31M(-3.1%) |
| Jun 2006 | - | $4.63M(-2.0%) | $18.88M(-0.5%) |
| Mar 2006 | - | $4.73M(-1.0%) | $18.98M(+1.4%) |
| Dec 2005 | $18.71M(+22.5%) | $4.78M(+0.6%) | $18.71M(+4.7%) |
| Sep 2005 | - | $4.75M(+0.5%) | $17.88M(+5.2%) |
| Jun 2005 | - | $4.72M(+5.9%) | $17.00M(+6.7%) |
| Mar 2005 | - | $4.46M(+13.0%) | $15.92M(+4.2%) |
| Dec 2004 | $15.28M(+6.6%) | $3.94M(+1.9%) | $15.28M(+2.1%) |
| Sep 2004 | - | $3.87M(+6.0%) | $14.96M(+2.3%) |
| Jun 2004 | - | $3.65M(-4.2%) | $14.62M(+0.8%) |
| Mar 2004 | - | $3.81M(+5.0%) | $14.51M(+1.3%) |
| Dec 2003 | $14.33M(+64.3%) | $3.63M(+2.8%) | $14.33M(+0.2%) |
| Sep 2003 | - | $3.53M(-0.3%) | $14.30M(+14.0%) |
| Jun 2003 | - | $3.54M(-2.4%) | $12.55M(+17.0%) |
| Mar 2003 | - | $3.63M(+0.6%) | $10.73M(+23.0%) |
| Dec 2002 | $8.72M(+32.7%) | $3.61M(+103.4%) | $8.72M(+35.3%) |
| Sep 2002 | - | $1.77M(+3.1%) | $6.45M(+1.0%) |
| Jun 2002 | - | $1.72M(+5.8%) | $6.38M(-1.8%) |
| Mar 2002 | - | $1.62M(+22.0%) | $6.50M(-1.1%) |
| Dec 2001 | $6.57M(-9.3%) | $1.33M(-22.2%) | $6.57M(-5.2%) |
| Sep 2001 | - | $1.71M(-6.8%) | $6.93M(+197.9%) |
| Jun 2001 | - | $1.83M(+8.1%) | $2.33M(-48.5%) |
| Mar 2001 | - | $1.70M(+0.5%) | $4.52M(-37.6%) |
| Dec 2000 | $7.25M(+2.0%) | $1.69M(-158.4%) | $7.25M(+252.4%) |
| Sep 2000 | - | -$2.89M(-171.9%) | $2.06M(-77.3%) |
| Jun 2000 | - | $4.03M(-9.0%) | $9.05M(+7.4%) |
| Mar 2000 | - | $4.42M(-226.4%) | $8.42M(+18.6%) |
| Dec 1999 | $7.10M(+57.8%) | -$3.50M(-185.4%) | $7.10M(-26.8%) |
| Sep 1999 | - | $4.10M(+20.6%) | $9.70M(+31.1%) |
| Jun 1999 | - | $3.40M(+9.7%) | $7.40M(+27.6%) |
| Mar 1999 | - | $3.10M(-444.4%) | $5.80M(+28.9%) |
| Dec 1998 | $4.50M(-54.1%) | -$900.00K(-150.0%) | $4.50M(-44.4%) |
| Sep 1998 | - | $1.80M(0.0%) | $8.10M(-8.0%) |
| Jun 1998 | - | $1.80M(0.0%) | $8.80M(-5.4%) |
| Mar 1998 | - | $1.80M(-33.3%) | $9.30M(-5.1%) |
| Dec 1997 | $9.80M(+4.3%) | $2.70M(+8.0%) | $9.80M(+2.1%) |
| Sep 1997 | - | $2.50M(+8.7%) | $9.60M(-17.9%) |
| Jun 1997 | - | $2.30M(0.0%) | $11.70M(+10.4%) |
| Mar 1997 | - | $2.30M(-8.0%) | $10.60M(+12.8%) |
| Dec 1996 | $9.40M(+154.1%) | $2.50M(-45.7%) | $9.40M(+36.2%) |
| Sep 1996 | - | $4.60M(+283.3%) | $6.90M(+200.0%) |
| Jun 1996 | - | $1.20M(+9.1%) | $2.30M(+109.1%) |
| Mar 1996 | - | $1.10M(+57.1%) | $1.10M(-60.7%) |
| Dec 1995 | $3.70M(+48.0%) | - | - |
| Mar 1995 | - | $700.00K(-50.0%) | $2.80M(+12.0%) |
| Dec 1994 | $2.50M | $1.40M(+250.0%) | $2.50M(+127.3%) |
| Sep 1994 | - | $400.00K(+33.3%) | $1.10M(+57.1%) |
| Jun 1994 | - | $300.00K(-25.0%) | $700.00K(+75.0%) |
| Mar 1994 | - | $400.00K | $400.00K |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual depreciation & amortization?
- What is the all time high annual D&A for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual D&A year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly D&A year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM depreciation & amortization?
- What is the all time high TTM D&A for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM D&A year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual depreciation & amortization?
The current annual D&A of LGND is $35.24M
What is the all time high annual D&A for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual depreciation & amortization is $51.53M
What is Ligand Pharmaceuticals Incorporated annual D&A year-on-year change?
Over the past year, LGND annual depreciation & amortization has changed by -$1.28M (-3.51%)
What is Ligand Pharmaceuticals Incorporated quarterly depreciation & amortization?
The current quarterly D&A of LGND is $8.77M
What is the all time high quarterly D&A for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly depreciation & amortization is $22.04M
What is Ligand Pharmaceuticals Incorporated quarterly D&A year-on-year change?
Over the past year, LGND quarterly depreciation & amortization has changed by +$5000.00 (+0.06%)
What is Ligand Pharmaceuticals Incorporated TTM depreciation & amortization?
The current TTM D&A of LGND is $35.24M
What is the all time high TTM D&A for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM depreciation & amortization is $53.18M
What is Ligand Pharmaceuticals Incorporated TTM D&A year-on-year change?
Over the past year, LGND TTM depreciation & amortization has changed by -$543.00K (-1.52%)